Dr. James Brooks's group's interest is in developing diagnostic and prognostic markers for urological diseases. Their work spans discovery, measurement methodologies, and clinical validation of candidate biomarkers. They have primarily used genomic and proteomic approaches for biomarker discovery. While their primary focus has been in prostate cancer, we have also worked in kidney cancer and other malignancies.
Dr. Jade Benjamin-Chung, PhD MPH, is an Assistant Professor at Stanford University in the Department of Epidemiology and Population Health and Chan Zuckerberg Biohub Investigator. Her group conducts research to identify interventions to control, eliminate, or eradicate environmentally-transmitted infectious diseases, including malaria, diarrhea, soil-transmitted helminths, and influenza.
Dr. Ivana Maric is an Assistant Professor in the Pediatrics Department at the Stanford University School of Medicine. Her research focuses on applying machine learning to improving maternal and neonatal health. Her main focus has been on developing machine learning models for early prediction of adverse outcomes of pregnancy from omics and electronic health records data, that could guide development of low-cost, point of care diagnostic tools. Her main interest is in solutions that are applicable worldwide and especially in low-resource settings.
